Tina Lohse1, Sabine Rohrmann1, Aline Richard1, Matthias Bopp1, David Faeh2. 1. Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. 2. Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland; Health Division - Nutrition and Dietetics, Bern University of Applied Sciences, Bern, Switzerland. Electronic address: david.faeh@uzh.ch.
Abstract
BACKGROUND AND AIMS: Type A behavior pattern (TABP) is a possible risk factor for cardiovascular disease (CVD). However, existing evidence is conflicting, also because studies did not examine underlying traits separately. In this study, we investigated whether all-cause and CVD mortality were associated with the Bortner Scale, a measure of TABP, in particular with its subscales competitiveness and speed. METHODS: Information on Bortner Scale and covariates of 9921 participants was collected at baseline in two cross-sectional studies that were linked with mortality information, yielding a follow-up of up to 37 years. We analyzed the Bortner Scale and its two subscales competitiveness and speed. Applying Cox regression models, we investigated the association with all-cause, CVD, and specific CVD type mortality. RESULTS: During follow-up, 3469 deaths were observed (1118 CVD deaths). The total Bortner Scale was not associated with mortality, only its subscales. In women, competitiveness was positively associated with all-cause mortality (highest category vs. the lowest, HR 1.25 [95% CI 1.08,1.44]), CVD mortality (1.39 [1.07,1.81]), and ischemic heart disease mortality (intermediate category vs. the lowest, 1.46 [1.02,2.10]). In men, CVD mortality was inversely associated with speed (highest category vs. the lowest, 0.74 [0.59,0.93]). CONCLUSIONS: The subscales of the Bortner Scale may be associated with CVD in an opposed manner and may therefore have to be analyzed separately. More studies are needed to further investigate this association, also considering differences by sex. Persons scoring high in the competitiveness subscale ought to be screened and counselled in order to reduce their CVD risk.
BACKGROUND AND AIMS: Type A behavior pattern (TABP) is a possible risk factor for cardiovascular disease (CVD). However, existing evidence is conflicting, also because studies did not examine underlying traits separately. In this study, we investigated whether all-cause and CVD mortality were associated with the Bortner Scale, a measure of TABP, in particular with its subscales competitiveness and speed. METHODS: Information on Bortner Scale and covariates of 9921 participants was collected at baseline in two cross-sectional studies that were linked with mortality information, yielding a follow-up of up to 37 years. We analyzed the Bortner Scale and its two subscales competitiveness and speed. Applying Cox regression models, we investigated the association with all-cause, CVD, and specific CVD type mortality. RESULTS: During follow-up, 3469 deaths were observed (1118 CVD deaths). The total Bortner Scale was not associated with mortality, only its subscales. In women, competitiveness was positively associated with all-cause mortality (highest category vs. the lowest, HR 1.25 [95% CI 1.08,1.44]), CVD mortality (1.39 [1.07,1.81]), and ischemic heart disease mortality (intermediate category vs. the lowest, 1.46 [1.02,2.10]). In men, CVD mortality was inversely associated with speed (highest category vs. the lowest, 0.74 [0.59,0.93]). CONCLUSIONS: The subscales of the Bortner Scale may be associated with CVD in an opposed manner and may therefore have to be analyzed separately. More studies are needed to further investigate this association, also considering differences by sex. Persons scoring high in the competitiveness subscale ought to be screened and counselled in order to reduce their CVD risk.
Authors: Juhua Luo; JoAnn E Manson; Julie C Weitlauf; Aladdin H Shadyab; Stephen R Rapp; Lorena Garcia; Junmei Miao Jonasson; Hilary A Tindle; Rami Nassir; Jean Wactawski-Wende; Michael Hendryx Journal: Menopause Date: 2019-01-21 Impact factor: 2.953
Authors: Kelsey T Laird; Helen Lavretsky; Pattharee Paholpak; Roza M Vlasova; Michael Roman; Natalie St Cyr; Prabha Siddarth Journal: Int Psychogeriatr Date: 2018-01-16 Impact factor: 3.878
Authors: Veerle R Smaardijk; Paul Lodder; Willem J Kop; Bente van Gennep; Angela H E M Maas; Paula M C Mommersteeg Journal: J Am Heart Assoc Date: 2019-05-07 Impact factor: 5.501
Authors: Karolina Chilicka; Aleksandra M Rogowska; Renata Szyguła; Ewa Adamczyk Journal: Int J Environ Res Public Health Date: 2020-11-17 Impact factor: 3.390